VEGFA and neoplasm: Metformin at a dose of 300 mg/kg day, but not 100 mg/kg day, significantly reduced expression levels of both VEGF and FGF‐2 in tumours (Figure 2D‐G), indicating the involvement of VEGF and FGF‐2 signalling in metformin‐induced anti‐angiogenesis.